About
Technology
Issues
FAQ
Links
Official Page
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.